Skip to main content
Erschienen in: Heart and Vessels 2/2019

07.08.2018 | Original Article

Adjunctive left anterior line ablation induced left atrial dysfunction and dyssynchrony in atrial fibrillation ablation

verfasst von: Hirosuke Yamaji, Takashi Murakami, Kazuyoshi Hina, Shunichi Higashiya, Hiroshi Kawamura, Masaaki Murakami, Shigeshi Kamikawa, Satoshi Hirohata, Shozo Kusachi

Erschienen in: Heart and Vessels | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

We evaluated the effects of adjunctive left anterior line (LAL) ablation on LA dyssynchrony and function using real-time three-dimensional echocardiography (3DE) in connection with thromboembolic complications and tachyarrhythmia recurrence in patients with persistent atrial fibrillation (AF). We randomly and prospectively assigned consecutive persistent AF patients to the LAL (n = 52, 65 ± 7 years) and control groups (n = 50, 64 ± 10 years). In the LAL group, extensive encircling pulmonary vein isolation (EEPVI), roof line ablation, and LAL ablation regardless of the extent of the low-voltage area (LVA) were performed. The control group underwent EEPVI and roof line ablation. After ablation, 3DE demonstrated LA dyssynchrony in 23 (46%) and 4 patients (8%, P < 0.001) of the LAL and control groups, respectively. Baseline LA LVAs were relatively small in most patients and there were no significant differences in extent of LVA between control and LAL groups or between patients with and without dyssynchrony. During the follow-up periods (771 ± 121 days), patients with LA dyssynchrony in the LAL group did not show significant differences in symptomatic thromboembolic events (0%) and atrial tachyarrhythmia recurrence (39%) from patients without LA dyssynchrony in the LAL (0% and 30%) and control groups (0% and 32%, respectively). LA ejection fraction and active emptying fraction were lower by 9% on average in the LAL group than in the control group (P < 0.0001). Similarly, in the LAL group, LA ejection fraction, active emptying fraction, and expansion index were significantly lower by approximately 7%, 8%, and 15%, respectively, in LA with dyssynchrony than those in LA without dyssynchrony. In conclusion, LA dyssynchrony and LA hypofunction were induced by LAL ablation in patients with persistent AF and relatively mild LVA. LAL ablation with or without LA dyssynchrony is thought not to affect thromboembolic complications or atrial tachyarrhythmia recurrence.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jiang Z, Yin H, He Y, Ma N, Tang M, Liu H, Ding F, Mei J (2015) Efficacy and safety of novel epicardial circumferential left atrial ablation with pulmonary vein isolation in sustained atrial fibrillation. Heart Vessels 30:675–681CrossRefPubMed Jiang Z, Yin H, He Y, Ma N, Tang M, Liu H, Ding F, Mei J (2015) Efficacy and safety of novel epicardial circumferential left atrial ablation with pulmonary vein isolation in sustained atrial fibrillation. Heart Vessels 30:675–681CrossRefPubMed
2.
Zurück zum Zitat Haissaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y, Rostock T, Hsu LF, Bordachar P, Reuter S, Roudaut R, Clementy J, Jais P (2005) Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 16:1138–1147CrossRefPubMed Haissaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y, Rostock T, Hsu LF, Bordachar P, Reuter S, Roudaut R, Clementy J, Jais P (2005) Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 16:1138–1147CrossRefPubMed
3.
Zurück zum Zitat Tzeis S, Luik A, Jilek C, Schmitt C, Estner HL, Wu J, Reents T, Fichtner S, Kolb C, Karch MR, Hessling G, Deisenhofer I (2010) The modified anterior line: an alternative linear lesion in perimitral flutter. J Cardiovasc Electrophysiol 21:665–670CrossRefPubMed Tzeis S, Luik A, Jilek C, Schmitt C, Estner HL, Wu J, Reents T, Fichtner S, Kolb C, Karch MR, Hessling G, Deisenhofer I (2010) The modified anterior line: an alternative linear lesion in perimitral flutter. J Cardiovasc Electrophysiol 21:665–670CrossRefPubMed
4.
Zurück zum Zitat Ammar S, Luik A, Hessling G, Bruhm A, Reents T, Semmler V, Buiatti A, Kathan S, Hofmann M, Kolb C, Schmitt C, Deisenhofer I (2015) Ablation of perimitral flutter: acute and long-term success of the modified anterior line. Europace 17:447–452CrossRefPubMed Ammar S, Luik A, Hessling G, Bruhm A, Reents T, Semmler V, Buiatti A, Kathan S, Hofmann M, Kolb C, Schmitt C, Deisenhofer I (2015) Ablation of perimitral flutter: acute and long-term success of the modified anterior line. Europace 17:447–452CrossRefPubMed
5.
Zurück zum Zitat (2000) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284:3043–3045 (2000) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284:3043–3045
6.
Zurück zum Zitat Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Komtasubara I, Kusachi S (2016) Adequate initial heparin dosage for atrial fibrillation ablation in patients receiving non-vitamin K antagonist oral anticoagulants. Clin Drug Investig 36:837–848CrossRefPubMedPubMedCentral Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Komtasubara I, Kusachi S (2016) Adequate initial heparin dosage for atrial fibrillation ablation in patients receiving non-vitamin K antagonist oral anticoagulants. Clin Drug Investig 36:837–848CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S (2013) Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation. Clin Drug Investig 33:409–418CrossRefPubMed Yamaji H, Murakami T, Hina K, Higashiya S, Kawamura H, Murakami M, Kamikawa S, Hirohata S, Kusachi S (2013) Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation. Clin Drug Investig 33:409–418CrossRefPubMed
8.
Zurück zum Zitat Piorkowski C, Eitel C, Rolf S, Bode K, Sommer P, Gaspar T, Kircher S, Wetzel U, Parwani AS, Boldt LH, Mende M, Bollmann A, Husser D, Dagres N, Esato M, Arya A, Haverkamp W, Hindricks G (2011) Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol 4:157–165CrossRefPubMed Piorkowski C, Eitel C, Rolf S, Bode K, Sommer P, Gaspar T, Kircher S, Wetzel U, Parwani AS, Boldt LH, Mende M, Bollmann A, Husser D, Dagres N, Esato M, Arya A, Haverkamp W, Hindricks G (2011) Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol 4:157–165CrossRefPubMed
9.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRefPubMed
10.
Zurück zum Zitat Marsan NA, Tops LF, Holman ER, Van de Veire NR, Zeppenfeld K, Boersma E, van der Wall EE, Schalij MJ, Bax JJ (2008) Comparison of left atrial volumes and function by real-time three-dimensional echocardiography in patients having catheter ablation for atrial fibrillation with persistence of sinus rhythm versus recurrent atrial fibrillation three months later. Am J Cardiol 102:847–853CrossRefPubMed Marsan NA, Tops LF, Holman ER, Van de Veire NR, Zeppenfeld K, Boersma E, van der Wall EE, Schalij MJ, Bax JJ (2008) Comparison of left atrial volumes and function by real-time three-dimensional echocardiography in patients having catheter ablation for atrial fibrillation with persistence of sinus rhythm versus recurrent atrial fibrillation three months later. Am J Cardiol 102:847–853CrossRefPubMed
11.
Zurück zum Zitat Murata M, Iwanaga S, Tamura Y, Kondo M, Kouyama K, Ogawa S (2008) A real-time three-dimensional echocardiographic quantitative analysis of left atrial function in left ventricular diastolic dysfunction. Am J Cardiol 102:1097–1102CrossRefPubMed Murata M, Iwanaga S, Tamura Y, Kondo M, Kouyama K, Ogawa S (2008) A real-time three-dimensional echocardiographic quantitative analysis of left atrial function in left ventricular diastolic dysfunction. Am J Cardiol 102:1097–1102CrossRefPubMed
12.
Zurück zum Zitat Aune E, Baekkevar M, Roislien J, Rodevand O, Otterstad JE (2009) Normal reference ranges for left and right atrial volume indexes and ejection fractions obtained with real-time three-dimensional echocardiography. Eur J Echocardiogr 10:738–744CrossRefPubMed Aune E, Baekkevar M, Roislien J, Rodevand O, Otterstad JE (2009) Normal reference ranges for left and right atrial volume indexes and ejection fractions obtained with real-time three-dimensional echocardiography. Eur J Echocardiogr 10:738–744CrossRefPubMed
13.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270CrossRefPubMed Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270CrossRefPubMed
14.
Zurück zum Zitat Anwar AM, Soliman OI, Geleijnse ML, Nemes A, Vletter WB, ten Cate FJ (2008) Assessment of left atrial volume and function by real-time three-dimensional echocardiography. Int J Cardiol 123:155–161CrossRefPubMed Anwar AM, Soliman OI, Geleijnse ML, Nemes A, Vletter WB, ten Cate FJ (2008) Assessment of left atrial volume and function by real-time three-dimensional echocardiography. Int J Cardiol 123:155–161CrossRefPubMed
15.
Zurück zum Zitat Schwartzman D, Ren JF, Devine WA, Callans DJ (2001) Cardiac swelling associated with linear radiofrequency ablation in the atrium. J Interv Card Electrophysiol 5:159–166CrossRefPubMed Schwartzman D, Ren JF, Devine WA, Callans DJ (2001) Cardiac swelling associated with linear radiofrequency ablation in the atrium. J Interv Card Electrophysiol 5:159–166CrossRefPubMed
16.
Zurück zum Zitat Okada T, Yamada T, Murakami Y, Yoshida N, Ninomiya Y, Shimizu T, Toyama J, Yoshida Y, Ito T, Tsuboi N, Kondo T, Inden Y, Hirai M, Murohara T (2007) Prevalence and severity of left atrial edema detected by electron beam tomography early after pulmonary vein ablation. J Am Coll Cardiol 49:1436–1442CrossRefPubMed Okada T, Yamada T, Murakami Y, Yoshida N, Ninomiya Y, Shimizu T, Toyama J, Yoshida Y, Ito T, Tsuboi N, Kondo T, Inden Y, Hirai M, Murohara T (2007) Prevalence and severity of left atrial edema detected by electron beam tomography early after pulmonary vein ablation. J Am Coll Cardiol 49:1436–1442CrossRefPubMed
17.
Zurück zum Zitat Verma N, Knight BP (2017) What happens during the blanking period does not stay in the blanking period. J Cardiovasc Electrophysiol 28:634–635CrossRefPubMed Verma N, Knight BP (2017) What happens during the blanking period does not stay in the blanking period. J Cardiovasc Electrophysiol 28:634–635CrossRefPubMed
18.
Zurück zum Zitat Alipour P, Azizi Z, Pirbaglou M, Ritvo P, Pantano A, Verma A, Khaykin Y (2017) Defining blanking period post pulmonary vein antrum isolation. JACC Clin Electrophysiol 3:568–576CrossRefPubMed Alipour P, Azizi Z, Pirbaglou M, Ritvo P, Pantano A, Verma A, Khaykin Y (2017) Defining blanking period post pulmonary vein antrum isolation. JACC Clin Electrophysiol 3:568–576CrossRefPubMed
19.
Zurück zum Zitat Jenkins C, Bricknell K, Chan J, Hanekom L, Marwick TH (2007) Comparison of two- and three-dimensional echocardiography with sequential magnetic resonance imaging for evaluating left ventricular volume and ejection fraction over time in patients with healed myocardial infarction. Am J Cardiol 99:300–306CrossRefPubMed Jenkins C, Bricknell K, Chan J, Hanekom L, Marwick TH (2007) Comparison of two- and three-dimensional echocardiography with sequential magnetic resonance imaging for evaluating left ventricular volume and ejection fraction over time in patients with healed myocardial infarction. Am J Cardiol 99:300–306CrossRefPubMed
20.
Zurück zum Zitat Grimm RA, Stewart WJ, Arheart K, Thomas JD, Klein AL (1997) Left atrial appendage “stunning” after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol 29:582–589CrossRefPubMed Grimm RA, Stewart WJ, Arheart K, Thomas JD, Klein AL (1997) Left atrial appendage “stunning” after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol 29:582–589CrossRefPubMed
21.
Zurück zum Zitat Ellis K, Ziada KM, Vivekananthan D, Latif AA, Shaaraoui M, Martin D, Grimm RA (2006) Transthoracic echocardiographic predictors of left atrial appendage thrombus. Am J Cardiol 97:421–425CrossRefPubMed Ellis K, Ziada KM, Vivekananthan D, Latif AA, Shaaraoui M, Martin D, Grimm RA (2006) Transthoracic echocardiographic predictors of left atrial appendage thrombus. Am J Cardiol 97:421–425CrossRefPubMed
22.
Zurück zum Zitat Santiago D, Warshofsky M, Li Mandri G, Di Tullio M, Coromilas J, Reiffel J, Homma S (1994) Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol 24:159–164CrossRefPubMed Santiago D, Warshofsky M, Li Mandri G, Di Tullio M, Coromilas J, Reiffel J, Homma S (1994) Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol 24:159–164CrossRefPubMed
23.
Zurück zum Zitat Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, Lellouche N, Knecht S, Wright M, Nault I, Miyazaki S, Scavee C, Clementy J, Haissaguerre M, Jais P (2011) Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 57:160–166CrossRefPubMed Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, Lellouche N, Knecht S, Wright M, Nault I, Miyazaki S, Scavee C, Clementy J, Haissaguerre M, Jais P (2011) Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 57:160–166CrossRefPubMed
24.
Zurück zum Zitat Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372:1812–1822CrossRefPubMed Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372:1812–1822CrossRefPubMed
25.
Zurück zum Zitat Wong KC, Paisey JR, Sopher M, Balasubramaniam R, Jones M, Qureshi N, Hayes CR, Ginks MR, Rajappan K, Bashir Y, Betts TR (2015) No benefit of complex fractionated atrial electrogram ablation in addition to circumferential pulmonary vein ablation and linear ablation: benefit of complex ablation study. Circ Arrhythm Electrophysiol 8:1316–1324CrossRefPubMed Wong KC, Paisey JR, Sopher M, Balasubramaniam R, Jones M, Qureshi N, Hayes CR, Ginks MR, Rajappan K, Bashir Y, Betts TR (2015) No benefit of complex fractionated atrial electrogram ablation in addition to circumferential pulmonary vein ablation and linear ablation: benefit of complex ablation study. Circ Arrhythm Electrophysiol 8:1316–1324CrossRefPubMed
26.
Zurück zum Zitat Rolf S, Kircher S, Arya A, Eitel C, Sommer P, Richter S, Gaspar T, Bollmann A, Altmann D, Piedra C, Hindricks G, Piorkowski C (2014) Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 7:825–833CrossRefPubMed Rolf S, Kircher S, Arya A, Eitel C, Sommer P, Richter S, Gaspar T, Bollmann A, Altmann D, Piedra C, Hindricks G, Piorkowski C (2014) Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 7:825–833CrossRefPubMed
27.
Zurück zum Zitat Jadidi AS, Lehrmann H, Keyl C, Sorrel J, Markstein V, Minners J, Park CI, Denis A, Jais P, Hocini M, Potocnik C, Allgeier J, Hochholzer W, Herrera-Sidloky C, Kim S, Omri YE, Neumann FJ, Weber R, Haissaguerre M, Arentz T (2016) Ablation of persistent atrial fibrillation targeting low-voltage areas with selective activation characteristics. Circ Arrhythm Electrophysiol 9:e002962PubMed Jadidi AS, Lehrmann H, Keyl C, Sorrel J, Markstein V, Minners J, Park CI, Denis A, Jais P, Hocini M, Potocnik C, Allgeier J, Hochholzer W, Herrera-Sidloky C, Kim S, Omri YE, Neumann FJ, Weber R, Haissaguerre M, Arentz T (2016) Ablation of persistent atrial fibrillation targeting low-voltage areas with selective activation characteristics. Circ Arrhythm Electrophysiol 9:e002962PubMed
28.
Zurück zum Zitat Yagishita A, Gimbel JR, De Oliveira S, Manyam H, Sparano D, Cakulev I, Mackall J, Arruda M (2017) Long-term outcome of left atrial voltage-guided substrate ablation during atrial fibrillation: a novel adjunctive ablation strategy. J Cardiovasc Electrophysiol 28:147–155CrossRefPubMed Yagishita A, Gimbel JR, De Oliveira S, Manyam H, Sparano D, Cakulev I, Mackall J, Arruda M (2017) Long-term outcome of left atrial voltage-guided substrate ablation during atrial fibrillation: a novel adjunctive ablation strategy. J Cardiovasc Electrophysiol 28:147–155CrossRefPubMed
Metadaten
Titel
Adjunctive left anterior line ablation induced left atrial dysfunction and dyssynchrony in atrial fibrillation ablation
verfasst von
Hirosuke Yamaji
Takashi Murakami
Kazuyoshi Hina
Shunichi Higashiya
Hiroshi Kawamura
Masaaki Murakami
Shigeshi Kamikawa
Satoshi Hirohata
Shozo Kusachi
Publikationsdatum
07.08.2018
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 2/2019
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-018-1238-x

Weitere Artikel der Ausgabe 2/2019

Heart and Vessels 2/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.